BC Week In Review | Apr 7, 2017
Financial News

MGB Biopharma completes venture financing

On April 6, infectious disease company MGB Biopharma Ltd. (Glasgow, U.K.) raised $1.2 million in a venture round led by existing investor Archangel Investors. Existing investors Tri Capital, Barwell and the Scottish Investment Bank also...
BC Week In Review | Sep 22, 2014
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Glasgow, U.K.   Business: Infectious   Date completed: 2014-09-17   Type: Venture financing   Raised: L2.7 million ($4.4 million)   Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; Scottish Enterprise  ...
BC Week In Review | Aug 5, 2013
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Glasgow, U.K.   Business: Infectious   Date completed: 7/25/13   Type: Venture financing   Raised: £600,000 ($923,640)   Investors: Archangel Informal Investment; Tweed Renaissance Investors (TRI) Capital; Barwell; Scottish Co-investment Fund  ...
BioCentury | Oct 31, 2011
Emerging Company Profile

MGB: Finding its groove

It has been known for decades that compounds binding to the minor groove of DNA can kill bacteria, but safety issues have prevented their development as antibiotics. MGB Biopharma Ltd. believes its compounds will get...
BC Week In Review | Apr 12, 2010
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Scotland, U.K.   Business: Infectious   Date completed: 4/6/10   Type: Venture financing   Raised: £2 million ($3 million)   Investors: Archangel Informal Investment; Tri Capital Ltd.; Barwell plc; Scottish Co-investment Fund...
BC Week In Review | Sep 14, 2009
Financial News

Lab901 completes venture financing

Lab901 Ltd. , Loanhead, U.K.   Business: Supply/Service   Date completed: 9/9/09   Type: Venture financing   Raised: £2.4 million ($3.9 million)   Investors: Archangel Informal Investment; Alliance Trust Equity Partners; Scottish Enterprise; Foresight 3 VCT;...
Items per page:
1 - 6 of 6
BC Week In Review | Apr 7, 2017
Financial News

MGB Biopharma completes venture financing

On April 6, infectious disease company MGB Biopharma Ltd. (Glasgow, U.K.) raised $1.2 million in a venture round led by existing investor Archangel Investors. Existing investors Tri Capital, Barwell and the Scottish Investment Bank also...
BC Week In Review | Sep 22, 2014
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Glasgow, U.K.   Business: Infectious   Date completed: 2014-09-17   Type: Venture financing   Raised: L2.7 million ($4.4 million)   Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; Scottish Enterprise  ...
BC Week In Review | Aug 5, 2013
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Glasgow, U.K.   Business: Infectious   Date completed: 7/25/13   Type: Venture financing   Raised: £600,000 ($923,640)   Investors: Archangel Informal Investment; Tweed Renaissance Investors (TRI) Capital; Barwell; Scottish Co-investment Fund  ...
BioCentury | Oct 31, 2011
Emerging Company Profile

MGB: Finding its groove

It has been known for decades that compounds binding to the minor groove of DNA can kill bacteria, but safety issues have prevented their development as antibiotics. MGB Biopharma Ltd. believes its compounds will get...
BC Week In Review | Apr 12, 2010
Financial News

MGB Biopharma completes venture financing

MGB Biopharma Ltd. , Scotland, U.K.   Business: Infectious   Date completed: 4/6/10   Type: Venture financing   Raised: £2 million ($3 million)   Investors: Archangel Informal Investment; Tri Capital Ltd.; Barwell plc; Scottish Co-investment Fund...
BC Week In Review | Sep 14, 2009
Financial News

Lab901 completes venture financing

Lab901 Ltd. , Loanhead, U.K.   Business: Supply/Service   Date completed: 9/9/09   Type: Venture financing   Raised: £2.4 million ($3.9 million)   Investors: Archangel Informal Investment; Alliance Trust Equity Partners; Scottish Enterprise; Foresight 3 VCT;...
Items per page:
1 - 6 of 6